Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia

Leukemia Research

Volumn 27, Issue 11, 2003, Pages 983-991

  Gupta, Vikas ^a   Minden, Mark D ^a   Yi, Qi Long ^b   Brandwein, Joseph ^a   Chun, Kathy ^c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

AML; Cytogenetics; Prognosis; Survival; Trisomy 4

Indexed keywords

AMSACRINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; MITOXANTRONE; TAMOXIFEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANAMNESIS; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CAUSE OF DEATH; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA ANALYSIS; DEMOGRAPHY; FEMALE; GENETIC RISK; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; MORPHOLOGY; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; SPLENOMEGALY; SURVIVAL RATE; SURVIVAL TIME; TRISOMY; TRISOMY 4;

EID: 0037633785     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00076-6     Document Type: Article

References (58)

1. Bloomfield C.D., Goldman A., Hassfeld D., de la Chapelle A. Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. In: Proceedings of the Fourth International Workshop on Chromosomes in Leukemia 1982. Cancer Genet Cytogenet. 11:1984;332.
2. Arthur D.C., Berger R., Golomb H.M., Swansbury G.J., R B., Alimena G.et al. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet. 40:1989;203.
3. Schiffer C.A., Lee E.J., Tomiyasu T., Wiernik P.H., Testa J.R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood. 73:1989;263.
4. Dastugue N., Payen C., Lafage-Pochitaloff M., Bernard P., Leroux D., Huguet-Rigal F.et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia. 9:1995;1491.
5. Mrozek K., Heinonen K., de la Chapelle A., Bloomfield C.D. Clinical significance of cytogenetics in acute myeloid leukemia. Semin. Oncol. 24:1997;17.
6. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G.et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 92:1998;2322.
7. Raimondi S.C., Chang M.N., Ravindranath Y., Behm F.G., Gresik M.V., Steuber C.P.et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood. 94:1999;3707.
8. Slovak M.L., Kopecky K.J., Cassileth P.A., Harrington D.H., Theil K.S., Mohamed A.et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a southwest oncology group/eastern cooperative oncology group study. Blood. 96:2000;4075.
9. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J.et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood. 98:2001;1312.
10. Byrd J.C., Mrozek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C.et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 100:2002;4325.
11. Bloomfield C.D., Lawrence D., Byrd J.C., Carroll A., Pettenati M.J., Tantravahi R.et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 58:1998;4173.
12. Byrd J.C., Dodge R.K., Carroll A., Baer M.R., Edwards C., Stamberg J.et al. Patients with t(821)(q22q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J. Clin. Oncol. 17:1999;3767.
13. Primary, single, autosomal trisomies associated with haematological disorders. United Kingdom Cancer Cytogenetics Group (UKCCG). Leuk Res 199216:841.
14. Farag S.S., Archer K.J., Mrozek K., Vardiman J.W., Carroll A.J., Pettenati M.J.et al. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Int. J. Oncol. 21:2002;1041.
15. Dohner H., Fisher K., del Valle F., Hartmann F., Pralle H., Fischer J.T.et al. Stratification of postremission therapy in adult acute myeloid leukemia according to the karyotype. First results of the AML HD93 multicenter treatment trial. Blood. 90:1997;584a.
16. Sierra J., Storer B., Hansen J.A., Martin P.J., Petersdorf E.W., Woolfrey A.et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant. 26:2000;397.
17. Mecucci C., Van Orshoven A., Tricot G., Michaux J.L., Delannoy A., Van den Berghe H. Trisomy 4 identifies a subset of acute nonlymphocytic leukemias. Blood. 67:1986;1328.
18. Sandberg A.A., Morgan R., Sait S.N., Berger R., Flandrin G., Schrier S.et al. Trisomy 4: an entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 26:1987;117.
19. Prieto F., Badia L., Orts M.A., Dieguez L., Amigo V. Trisomy 4: another specific anomaly in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 26:1987;171.
20. Suciu S., Weh H.J., Kuse R., Meier C.B., Hossfeld D.K. Trisomy 4 in two cases of acute myelomonocytic leukemia. Cancer Genet Cytogenet. 33:1988;19.
21. Hoyle C.F., Boughton B.J., Hayhoe F.G. Two further cases of acute myeloid leukemia with trisomy 4. Cancer Genet Cytogenet. 34:1988;29.
22. Horsman D.E., Pantzar J.T., Kalousek D.K. Trisomy 4 in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 36:1988;155.
23. Yokota S., Taniwaki M., Okuda T., Maekawa T., Nishida K., Misawa S.et al. Acute nonlymphocytic leukemia (M2) with chromosome abnormality trisomy 4 developing 8 years after radiation therapy for breast cancer. Blut. 58:1989;27.
24. Banno S., Hirashima N., Noda T., Nitta M. Chromosomal abnormality of trisomy 4 in a patient with acute nonlymphocytic leukemia (FAB: M2). Rinsho Ketsueki. 30:1989;1987.
25. Temperani P., Zucchini P., Artusi T., Sacchi S., Emilia G. Acute nonlymphocytic leukemia with trisomy 4. Cancer Genet Cytogenet. 41:1989;203.
26. Thompson P.W., Thompson E.N., Whittaker J.A.et al. Four cases of acute leukemia with trisomy. Cancer Genet Cytogenet 4. 43:1989;211.
27. Weber E., Nowotny H., Haas O.A., Kasparu H., Grois N., Lutz D. Trisomy 4: a specific karyotype anomaly in primary and secondary acute myeloid leukemia. Leukemia. 4:1990;219.
28. Kao Y.S., McCormick C., Vial R. Trisomy 4 in a case of acute undifferentiated myeloblastic leukemia with hand-mirror cells. Cancer Genet Cytogenet. 45:1990;265.
29. Kwong Y.L., Ha S.Y., Liu H.W., Chan L.C. Trisomy 4 may occur in a broad range of hematologic malignancies. Cancer Genet Cytogenet. 69:1993;139.
30. Pedersen B. Trisomy 4: clinical picture, hematology and survival. Presentation of two cases and review of the literature. Hematol. Pathol. 6:1992;161.
31. Donti E., Maccari A., Tabilio A., Ardisia C., Campanari N., Donti G.V. Trisomy 4 in acute nonlymphocytic leukemia. Report of two cases and review of the literature. Cancer Genet Cytogenet. 60:1992;195.
32. Zollino M., Leone G., Sica S., Bajer J., Neri G. Trisomy 4 in acute myeloblastic and acute lymphoblastic leukemia. Cancer Genet Cytogenet. 65:1993;115.
33. al-Bahar S., Pandita R., Owade J.M., al Aasar E.M. Trisomy 4 and de novo acute myelomonocytic leukemia in a Kuwaiti patient. Cancer Genet Cytogenet. 68:1993;147.
34. Ribeiro E.M., Cavalli I.J., Tokutake A.S., Sperandio-Roxo V.M., Malvezzi M., Pasquini R. Trisomy 4 in acute nonlymphocytic leukemia: the first Brazilian case. Cancer Genet Cytogenet. 68:1993;82.
35. Thompson P.W., Whittaker J.A., Brennan H. Trisomy 4 with double minute chromosomes in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 69:1993;41.
36. Suenaga M., Sanada I., Tsukamoto A., Sato M., Kawano F., Shido T.et al. Trisomy 4 in a case of acute myelogenous leukemia accompanied by subcutaneous soft tissue tumors. Report of a case and review of the literature. Cancer Genet Cytogenet. 71:1993;71.
37. Keung Y.K., Kaplan B., Douer D. Biphenotypic M0 acute myeloid leukemia with trisomy-4. Leuk. Lymphoma. 14:1994;181.
38. Feuring-Buske M., Haase D., Konemann S., Troff C., Grove D., Hiddemann W.et al. Trisomy 4 in 'stem cell-like' leukemic cells of a patient with AML. Leukemia. 9:1995;1318.
39. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457.
40. Alitalo K., Saksela K., Winqvist R., Alitalo R., Keski-Oja J., Laiho M.et al. Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes. Lancet. 2:1985;1035.
41. Juneja S., Brown J., Ding J.C., Garson O.M. Trisomy 4 in acute nonlymphocytic leukemia. An Australian case. Cancer Genet Cytogenet. 34:1988;25.
42. Parry S.H., Gibbons B., Czepulkowski B.H., Amess J.A., Oxley V.E. A further case of acute myelogenous leukemia with trisomy 4 and double minutes. Cancer Genet Cytogenet. 39:1989;295.
43. Akiyoshi T.T., Kimura N., Uike N., Kozuru M., Tamura K., Takihara Y.et al. Genotypic and cytogenetic study of acute myelocytic leukemia and chronic myelocytic leukemia in blast crisis: specific delta rearrangement pattern does not involve J delta gene locus. Leuk Res. 15:1991;683.
44. Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation. A report on 94 cases. Groupe Francais de Cytogenetique Hematologique (GFCH). Hematol Cell Ther 199638:177.
45. Fugazza G., Bruzzone R., Puppo L., Patrone F., Sessarego M. Amplified c-MYC sequences localized by fluorescence in situ hybridization on double minute chromosomes in acute myeloid leukemias. Leuk Res. 21:1997;703.
46. Ramond S., Delmer A., Cymbalista-Ajchembaum F., Cadiou M., Viguie F., Zittoun R.et al. Another case of trisomy 4 with double minute chromosomes in acute non-lymphocytic leukemia. Cancer Genet Cytogenet. 83:1995;165.
47. O'Malley F., Rayeroux K., Cole-Sinclair M., Tong M., Campbell L.J. MYC amplification in two further cases of acute myeloid leukemia with trisomy 4 and double minute chromosomes. Cancer Genet Cytogenet. 109:1999;123.
48. Clavio M., Gatto S., Beltrami G., Cerri R., Carrara P., Pierri I.et al. First line therapy with fludarabine combinations in 42 patients with either postmyelodysplastic syndrome or therapy related acute myeloid leukaemia. Leuk Lymphoma. 40:2001;305.
49. Sandberg A.A., Van den Berghe H., Hecht F. Trisomy 4 in hematologic disorders. Cancer Genet Cytogenet. 26:1987;175.
50. Cartwright R.A., Gurney K.A., Moorman A.V. Sex ratios and the risks of haematological malignancies. Br. J. Haematol. 118:2002;1071.
51. Mertens F., Johansson B., Mitelman F. Age- and gender-related heterogeneity of cancer chromosome aberrations. Cancer Genet Cytogenet. 70:1993;6.
52. Mauritzson N., Johansson B., Albin M., Billstrom R., Ahlgren T., Mikoczy Z.et al. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology. Eur. J. Haematol. 62:1999;95.
53. Heim S., Mitelman F. Numerical chromosome aberrations in human neoplasia. Cancer Genet Cytogenet. 22:1986;99.
54. Spritz R.A., Strunk K.M., Lee S.T., Lu-Kuo J.M., Ward D.C., Le Paslier D.et al. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12. Genomics. 22:1994;431.
55. Gari M., Goodeve A., Wilson G., Winship P., Langabeer S., Linch D.et al. c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. Br. J. Haematol. 105:1999;894.
56. Beghini A., Peterlongo P., Ripamonti C.B., Larizza L., Cairoli R., Morra E.et al. c-kit mutations in core binding factor leukemias. Blood. 95:2000;726.
57. Beghini A., Ripamonti C.B., Castorina P., Pezzetti L., Doneda L., Cairoli R.et al. Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement. Cancer Genet Cytogenet. 119:2000;26.
58. Zhuang Z., Park W.S., Pack S., Schmidt L., Vortmeyer A.O., Pak E.et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nat. Genet. 20:1998;66.